the aid library

LIST OPTIONS

Filter

6945

Download (268)

View PDF (475)

Deltyba® (Delamanid): Behandlungsleitfaden für Ärzte

Bundesinstitut für Arzneimittel und Mediziprodukte (2015) C2

Information für Ärzte.

Download (195)

View PDF (275)

Influencing food environments for healthy diets

Food and Agriculture Organization of the United Nations FAO (2016) C2

Food environments are usually defined as the settings with all the different types of food made available and accessible to people as they go about their daily lives. That is, the range of food in supermarkets, small retail outlets, wet markets, street food stalls, coffee shops, tea houses, s...chool canteens, restaurants, and all the other venues where people buy and eat food. These environments differ enormously depending on the context. They can be extensive and diverse, with a seemingly endless array of options and price ranges, or they can be sparse, with very few options on offer. Because they determine what food consumers can access at a given moment in time, at what price, and with what degree of convenience, food environments both constrain and prompt the consumer’s choice.Food environments are influenced by the food systems which supply them, and vice versa. Food systems encompass the entire range of activities, people and institutions involved in the production, processing, marketing, consumption and disposal of food (FAO, 2013). They include but are not limited to food supply chains. Making food systems nutrition-sensitive can contribute to addressing all forms of malnutrition, as food systems determine whether the food needed for good nutrition are available, affordable, acceptable and of adequate quantity and quality. How closely food systems and food environments are interrelated and interdependent, and the degree to which external factors affect nutrition outcomes, varies from setting to setting.Many of today’s food systems and food environments are challenged in supporting consumer choices that are consistent with healthy diets and good nutrition. Consumers are not making choices based on nutrition and health, and poor diet is now the number one risk factor for death and disability worldwide (GBD, 2015). Food systems that do not enable healthy diets are increasingly recognized as an underlying cause of malnutrition (GLOPAN, 2016), and malnutrition, irrespective of form, has a huge cost. Economic costs associated with undernutrition are estimated at $1-2 trillion per year, about 2-3% of global GDP (FAO, 2013); the global economic cost of obesity and associated diet-related non-communicable diseases is estimated at $2 trillion per year, about 2.8% of global GDP (McKinsey, 2014). Influencing food environments for promoting healthy diets is an emerging strategy to address today’s nutrition challenges. more

Download (247)

View PDF (258)

Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19: interim guidance, 20 December 2021

World Health Organization WHO (2022) C_WHO

27 September 2022 These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.

External Link

Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact

Cupertino, M. C.; Resende, M. B.; et al (2020) C2

Infectious diseases continue to impose unpredictable burdens on global health and economies, a subject that requires constant research and updates. In this sense, the objective of the present article was to review studies on the role of wild animals as reservoirs and/or dispersers of etiological age... more

Download (293)

View PDF (281)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 25 April 2022: updated chapter: mask use, part 1: health care settings
recommended

World Health Organization WHO (2022) C_WHO

22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of variants of conc... more

Download (137)

View PDF (181)

Policy brief: mainstreaming quality of care in empanelled hospitals under AB PM-JAY

World Health Organisation (WHO) (2022) C_WHO

This report presents key findings from a study carried out on the ‘Mainstreaming quality of care in empanelled hospitals under PMJAY’. It provides a detailed analysis of current coverage and perceptions of quality accreditation and certification across PMJAY empanelled hospitals from three diffe... more

Download (151)

View PDF (188)

Target product profile for a test for rhodesiense human African trypanosomiasis diagnosis usable in peripheral health facilities

World Health Organization WHO (2021) C_WHO

The development of this target product profile (TPP) was led by the WHO Department of Control of Ne- glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was... more

Download (178)

View PDF (186)

The Evolution of Official Development Assistance

Hynes W.; Scott S. OECD (2013) CC

The definition of Official Development Assistance (ODA) has for 40 years been the global standard for measuring donor efforts in supporting development co-operation objectives. It has provided the yardstick for documenting the volume and the terms of the concessional resources provided, assessing do... more

Download (91)

View PDF (89)

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries

Bazargani, Y.T.; Ugurlu, M.; Leufkens, H.G.M. et al. BMC Cardiovascular Disorders (2018) CC

The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE... more

Download (108)

View PDF (120)

Achieving Control of Asthma in Children in Africa (ACACIA): protocol of an observational study of children’s lung health in six sub-Saharan African countries

Mosler, G.; Oyenuga, V.; Addo-Yobo, E. et al. BMJ Open (2020) CC

Little is known about asthma control in the rising number of African children who suffer from this condition. The Achieving Control of Asthma in Children in Africa (ACACIA) study is an observational study collecting evidence about paediatric asthma in urban areas of Ghana, Malawi, Nigeria, South Afr... more

Download (2511)

View PDF (4009)

WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicine
recommended

World Health Organization WHO (2007) C_WHO

The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.

Download (1759)

View PDF (2245)

MSF Qualification Scheme for International Pharmaceutical Supply

Medicins Sans Frontieres (2009) CC

The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch... more

Download (1106)

View PDF (1644)

WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems

World Health Organization WHO (2015) C_WHO

This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin... more

Download (249)

View PDF (332)

Método madre canguro : guía práctica
recommended

Organización Mundial de la Salud OMS (2003) C_WHO

Los cuidados de la madre canguro son un método de atención a los bebés prematuros. El método consiste en llevar a los bebés, normalmente por la madre, con contacto piel con piel. Esta guía está dirigida a los profesionales de la salud responsables del cuidado de los recién nacidos de bajo pe... more

Download (1351)

View PDF (6458)

Essential obstetric and newborn care
recommended

Anne-Sophie Coutin, et al. Médecins sans Frontières MSF (2019) C1

Essential obstetric and newborn care is designed as a tool to help protect mothers and their children in adverse environments. It is intended for midwives, doctors with obstetrics training, and health care personnel who deal with obstetric emergencies.

Download (210)

View PDF (293)

Laboratory testing for the monkeypox virus
recommended

World Health Organization (WHO) (2022) C_WHO

Any individual that meets the suspected case definition of monkeypox should be offered testing in appropriately equipped laboratories by staff trained in the relevant technical and safety procedures. Confirmation of monkeypox virus infection is based on nucleic acid amplification testing (NAAT), usi... more

Download (189)

View PDF (225)

High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries

Bortone, B.; et al. (2021) CC

PlosOne January 20, 2021 https://doi.org/10.1371/journal.pone.0241899 Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim... more

Download (297)

View PDF (267)

Guideline for Adverse Drug Reactions Reporting for Healthcare Professionals

SAHPRA (2020) CC

Communication to Healthcare Professionals Mar-2020 This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o... more

Download (294)

View PDF (228)

A Guidance for Tuberculosis Prevention and Control in Indigenous Populations in the Region of the Americas

Pan American Health Organisation PAHO (2021) C_WHO

Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t... more

Download (408)

View PDF (1466)

Multi-sector Nutrition Plan for Accelerated Reduction of Maternal and Child Under-nutrition 2013-2017

Government of Nepal, National Planning Commission (2012) C1

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 25 April 2022: updated chapter: mask use, part 1: health care settings recommended

WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicine recommended

Método madre canguro : guía práctica recommended

Essential obstetric and newborn care recommended

Laboratory testing for the monkeypox virus recommended

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 25 April 2022: updated chapter: mask use, part 1: health care settings
recommended

WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicine
recommended

Método madre canguro : guía práctica
recommended

Essential obstetric and newborn care
recommended

Laboratory testing for the monkeypox virus
recommended